Advertisement
Advertisement
TOPIC

China’s private sector

China’s private sector
The latest news, analysis and opinion on China’s private sector. In-depth analysis, industry insights and expert opinion.
United States

Chinese biotech giant WuXi AppTec raises 2026 outlook after profit surge

Strong demand for drug development drove the forecast, though the firm faces ongoing scrutiny from Washington.

In Focus | What will China’s fifth plenum mean for the root-and-branch corruption drive?

videocam

In Focus | ‘Rampant’ unpaid debts, rising costs: why China’s private sector is hurting

With an economic slowdown adding to their woes, China’s private businesspeople lament heightened regulatory enforcement as a further strain.

videocam
Advertisement
Advertisement
Advertisement

China wants 5 innovative drugs with US$1b returns by 2030. Which might they be?

Beijing is attempting to have at least five pharmaceutical products with annual global sales of more than US$1 billion.

videocam
China is attempting to boost the sales of at least five of its drugs to US$1 billion by 2030. Photo: Shutterstock
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement